Neopterin as an inflammatory biomarker in heart failure
Description
The pathophysiological changes that occur in heart failure leads to the release of neopterin and increase in its serum levels. Neopterin levels correlate well with disease severity and prognosis of the diseases. It is a valuable biomarker for grading, diagnosis, prognosis and assessment of therapy effectiveness.
Acknowledgements
References
-Dogheim GM, Amralla MT, Werida RH. Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level. Inflammopharmacology. 2022;30(5):1617-1622. doi:10.1007/s10787-022-01028-5
-Dogheim, G. M., Khairat, I., Omran, G. A., El-Haggar, S. M., Amrawy, A. M. E., & Werida, R. H. (2022). Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients. European journal of clinical pharmacology, 78(6), 943–954. https://doi.org/10.1007/s00228-022-03290-6
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures
.gif)
